Authors:
LIOURE B
WIHLM J
DIMITROV Y
ABDELKEFI A
MALOISEL F
LIU KL
LAPLACE A
MOULIN B
OBERLING F
Citation: B. Lioure et al., HIGH-DOSE MELPHALAN (HDM) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR MYELOMA (MM) PATIENTS WITH SEVERE RENAL-FAILURE - PHARMACOKINETIC STUDY - CORRELATION BETWEEN BIOLOGY AND CLINICS, Bone marrow transplantation, 21, 1998, pp. 705-705
Authors:
WIHLM J
LIMACHER JM
LEVEQUE D
DUCLOS B
BERGERAT JP
METHLIN G
Citation: J. Wihlm et al., PHARMACOKINETICS OF HIGH-DOSE DOXORUBICIN ADMINISTERED AS A 6-H INTRAVENOUS-INFUSION IN BREAST-CANCER PATIENTS, Bulletin du cancer, 84(6), 1997, pp. 603-608
Authors:
LIMACHER JM
DUCLOS B
WIHLM J
LEVEQUE D
DUFOUR P
EICHLER F
KEILING R
BERGERAT JP
Citation: Jm. Limacher et al., PHASE-I STUDY OF HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID IN WEEKLY CONTINUOUS-INFUSION, European journal of cancer, 31A, 1995, pp. 945-945
Citation: J. Wihlm et al., PHARMACODYNAMICS OF 5-FLUOROURACIL COMBINED WITH CARBOPLATIN IN PATIENTS WITH HEAD AND NECK-CANCER, Anticancer research, 14(6A), 1994, pp. 2395-2396
Authors:
LEVEQUE D
MERLEMELET M
BRESLER L
DIDELOT JP
AYMARD JP
WIHLM J
JEHL F
Citation: D. Leveque et al., BILIARY ELIMINATION AND PHARMACOKINETICS OF VINORELBINE IN MICROPIGS, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 487-490
Citation: J. Wihlm et al., THERAPEUTIC DRUG-MONITORING WITH DOSE ADJUSTMENT OF 5-FU ADMINISTRATED BY CONTINUOUS-INFUSION, Bulletin du cancer, 80(5), 1993, pp. 439-445